These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37596322)

  • 1. AKIP1 accelerates glioblastoma progression through stabilizing EGFR expression.
    Wan S; Liu C; Li C; Wang Z; Zhao G; Li J; Ran W; Zhong X; Li Y; Zhang L; Cui H
    Oncogene; 2023 Sep; 42(39):2905-2918. PubMed ID: 37596322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of A-kinase interacting protein 1 in regulating progression and stemness as well as indicating the prognosis in glioblastoma.
    Tang J; Peng S; Yan H; Ni M; Hou X; Ma P; Li Y
    Transl Oncol; 2022 Aug; 22():101463. PubMed ID: 35691247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of AKIP1 Suppresses the Proliferation, Migration, and Epithelial-Mesenchymal Transition Process of Glioma Cells by Upregulating DLG2.
    Chen Z; Wen H; Zhang J; Zou X; Wu S
    Biomed Res Int; 2022; 2022():5648011. PubMed ID: 35111846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
    Zhang X; Liu S; Zhu Y
    Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.
    Li M; Mukasa A; Inda MM; Zhang J; Chin L; Cavenee W; Furnari F
    J Exp Med; 2011 Dec; 208(13):2657-73. PubMed ID: 22162832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A-kinase-interacting protein 1 overexpression correlates with deteriorative tumor features and worse survival profiles, and promotes cell proliferation but represses apoptosis in non-small-cell lung cancer.
    Chen H; Yan S; Dong L; Li X
    J Clin Lab Anal; 2020 Feb; 34(2):e23061. PubMed ID: 31828834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of AKIP1 promotes angiogenesis and lymphangiogenesis in human esophageal squamous cell carcinoma.
    Lin C; Song L; Liu A; Gong H; Lin X; Wu J; Li M; Li J
    Oncogene; 2015 Jan; 34(3):384-93. PubMed ID: 24413079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A-kinase-interacting protein 1 facilitates growth and metastasis of gastric cancer cells via Slug-induced epithelial-mesenchymal transition.
    Chen D; Cao G; Liu Q
    J Cell Mol Med; 2019 Jun; 23(6):4434-4442. PubMed ID: 31020809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A-kinase interacting protein 1 is sufficiently expressed and positively associates with WHO grade, meanwhile predicts unfavorable overall survival independently in glioma patients.
    Shen S; Yao Y
    Medicine (Baltimore); 2021 Jan; 100(4):e20426. PubMed ID: 33530151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AKIP1 promotes angiogenesis and tumor growth by upregulating CXC-chemokines in cervical cancer cells.
    Zhang W; Wu Q; Wang C; Yang L; Liu P; Ma C
    Mol Cell Biochem; 2018 Nov; 448(1-2):311-320. PubMed ID: 29520695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma.
    Su L; Guo W; Lou L; Nie S; Zhang Q; Liu Y; Chang Y; Zhang X; Li Y; Shen H
    Mol Carcinog; 2020 May; 59(5):520-532. PubMed ID: 32134157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CBX3 accelerates the malignant progression of glioblastoma multiforme by stabilizing EGFR expression.
    Peng W; Shi S; Zhong J; Liang H; Hou J; Hu X; Wang F; Zhang J; Geng S; Sun X; Zhong D; Cui H
    Oncogene; 2022 May; 41(22):3051-3063. PubMed ID: 35459780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AKIP1 promotes glioblastoma viability, mobility and chemoradiation resistance via regulating CXCL1 and CXCL8 mediated NF-κB and AKT pathways.
    Han D; Zhang N; Zhao S; Liu H; Wang X; Yang M; Wang S; Li Y; Liu Z; Teng L
    Am J Cancer Res; 2021; 11(4):1185-1205. PubMed ID: 33948353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AKIP1 expression in tumor tissue as a new biomarker for disease monitoring and prognosis in non-small cell lung cancer: Results of a retrospective study.
    Liu Y; Tian J; Qin D; Liu J; Xie Y
    J Clin Lab Anal; 2020 Apr; 34(4):e23128. PubMed ID: 31782840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA circ_0001588 sponges miR-211-5p to facilitate the progression of glioblastoma via up-regulating YY1 expression.
    Wang Q; Zheng D; Li Y; Zhang Y; Sui R; Chen Y; Liang H; Shi J; Pan R; Xu X; Sun D
    J Gene Med; 2021 Oct; 23(10):e3371. PubMed ID: 34105224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FHL2 interacts with EGFR to promote glioblastoma growth.
    Sun L; Yu S; Xu H; Zheng Y; Lin J; Wu M; Wang J; Wang A; Lan Q; Furnari F; Cavenee W; Purow B; Li M
    Oncogene; 2018 Mar; 37(10):1386-1398. PubMed ID: 29321665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AKIP1 promotes early recurrence of hepatocellular carcinoma through activating the Wnt/β-catenin/CBP signaling pathway.
    Cui Y; Wu X; Lin C; Zhang X; Ye L; Ren L; Chen M; Yang M; Li Y; Li M; Li J; Guan J; Song L
    Oncogene; 2019 Jul; 38(27):5516-5529. PubMed ID: 30936461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A-kinase-interacting protein 1 (AKIP1) acts as a molecular determinant of PKA in NF-kappaB signaling.
    Gao N; Hibi Y; Cueno M; Asamitsu K; Okamoto T
    J Biol Chem; 2010 Sep; 285(36):28097-104. PubMed ID: 20562110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling.
    Xiao Q; Dong M; Cheng F; Mao F; Zong W; Wu K; Wang H; Xie R; Wang B; Lei T; Guo D
    Int J Oncol; 2018 Sep; 53(3):1069-1082. PubMed ID: 30015847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.